|
TSPAN14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.008010E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.588210E-01 |
| Normal-vs-Stage2 |
6.879200E-01 |
| Normal-vs-Stage3 |
7.237100E-04 |
| Normal-vs-Stage4 |
3.449400E-04 |
| Stage1-vs-Stage2 |
5.284000E-01 |
| Stage1-vs-Stage3 |
2.999600E-03 |
| Stage1-vs-Stage4 |
2.537800E-03 |
| Stage2-vs-Stage3 |
1.519730E-02 |
| Stage2-vs-Stage4 |
1.179570E-02 |
| Stage3-vs-Stage4 |
4.926200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.741570E-02 |
| Normal-vs-AfricanAmerican |
8.303800E-02 |
| Normal-vs-Asian |
8.579400E-03 |
| Caucasian-vs-AfricanAmerican |
8.444200E-01 |
| Caucasian-vs-Asian |
3.421200E-01 |
| AfricanAmerican-vs-Asian |
6.112800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.487640E-01 |
| Normal-vs-Female |
1.130030E-02 |
| Male-vs-Female |
2.698400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.344200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.716900E-03 |
| Normal-vs-Age(61-80Yrs) |
3.002400E-03 |
| Normal-vs-Age(81-100Yrs) |
8.602400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.084300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.766100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.250200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.478400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.950200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.224600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.056500E-03 |
| Classical-VS-Follicular |
1.829920E-02 |
| Classical-VS-Other |
9.357400E-01 |
| Classical-VS-Normal |
1.269550E-02 |
| Tall-VS-Follicular |
3.59109999999996E-05 |
| Tall-VS-Other |
1.184770E-01 |
| Tall-VS-Normal |
2.0705999999926E-05 |
| Follicular-VS-Other |
5.006400E-01 |
| Follicular-VS-Normal |
8.372200E-01 |
| Other-VS-Normal |
3.610800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.402100E-02 |
| Normal-vs-N1 |
4.953700E-04 |
| N0-vs-N1 |
1.079560E-02 |
|
|
